Researchers have introduced PathoPlex, a novel multiplexing imaging platform that enables high-dimensional, spatially-resolved analysis of immune-mediated kidney diseases. This breakthrough technology offers unparalleled insights into renal pathology at cellular and molecular levels, promising to transform disease understanding and therapeutic targeting. The study highlights the potential of integrating such platforms into clinical and research applications for better disease mapping and management.